Nasdaq Stockholm

Isofol Medical AB (publ)

ISIN SE0009581051Filings at the FI

At a glance

Most recent filing on October 9, 2026 — an open-market purchase by Helena Taflin on Oct 6, 2026.

We hold 13 visible filings, going back to December 19, 2018.

Filings we could not classify with confidence are set aside for review, so they are in none of these counts.

Insider trades

What is a MAR filing?

5 of 13 shown

This page is free to read, and it stops after 5 rows. Those are the 5 most recent filings at this company, out of 13. Reading the whole list, and the full version of the page each row opens (that page itself opens free, with its first rows), is part of the subscription. So are the price history with every buy marked, the price change beside each line, and any moments with several buyers or buying streaks. What that costs is on the pricing page. Already subscribed? Sign in and this page opens in full.

Helena Taflin Board member
48,510 SEKOpen-market buy
TradedOct 6, 2026FiledOct 9, 2026
Margareta Hagman Chief financial officer
102,400 SEKOpen-market buy
TradedSep 23, 2024FiledSep 23, 2024
Magnus Hurst Chief financial officer
91,235 SEKOpen-market sale
TradedSep 13, 2024FiledSep 16, 2024
Petter Segelman Lindqvist Chief executive officer
20,956 SEKOpen-market buy
TradedAug 21, 2024FiledAug 21, 2024
Petter Segelman Lindqvist Chief executive officer
19,170 SEKOpen-market buy
TradedJul 12, 2024FiledJul 12, 2024